These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
65. [Interferon beta 1-a in multiple sclerosis: 1-year experience in 62 patients]. Tilbery CP; Felipe E; Moreira MA; Mendes MF; França AS Arq Neuropsiquiatr; 2000 Jun; 58(2B):452-9. PubMed ID: 10920406 [TBL] [Abstract][Full Text] [Related]
66. Enhanced spasticity in primary progressive MS patients treated with interferon beta-1b. Frese A; Bethke F; Lüdemann P; Stögbauer F Neurology; 1999 Nov; 53(8):1892-3. PubMed ID: 10563657 [No Abstract] [Full Text] [Related]
67. [Multiple sclerosis: therapy with recombinant beta-1b interferon: initial results with 30 multiple sclerosis patients in northwest Switzerland]. Huber S; Spycher M; Lechner-Scott J; Bellaiche Y; Steck AJ; Kappos L Schweiz Med Wochenschr; 1996 Aug; 126(35):1475-81. PubMed ID: 8927950 [TBL] [Abstract][Full Text] [Related]
68. Effect of interferon beta-1a subcutaneously three times weekly on clinical and radiological measures and no evidence of disease activity status in patients with relapsing-remitting multiple sclerosis at year 1. Traboulsee A; Li DKB; Cascione M; Fang J; Dangond F; Miller A BMC Neurol; 2018 Sep; 18(1):143. PubMed ID: 30217172 [TBL] [Abstract][Full Text] [Related]
69. Does interferon beta help in secondary progressive MS? Cohen JA; Antel JP Neurology; 2004 Nov; 63(10):1768-9. PubMed ID: 15557486 [No Abstract] [Full Text] [Related]
71. New treatments for multiple sclerosis. Hutchinson M Ir Med J; 1996; 89(2):44. PubMed ID: 8682623 [No Abstract] [Full Text] [Related]
72. Long-term treatment of multiple sclerosis with interferon-beta may be cost effective. Kendrick M; Johnson KI Pharmacoeconomics; 2000 Jul; 18(1):45-53. PubMed ID: 11010603 [TBL] [Abstract][Full Text] [Related]
74. Interferon beta for multiple sclerosis. Connelly JF Ann Pharmacother; 1994 May; 28(5):610-6. PubMed ID: 8069001 [TBL] [Abstract][Full Text] [Related]
75. Magnetic resonance imaging results of the PRISMS trial: a randomized, double-blind, placebo-controlled study of interferon-beta1a in relapsing-remitting multiple sclerosis. Prevention of Relapses and Disability by Interferon-beta1a Subcutaneously in Multiple Sclerosis. Li DK; Paty DW Ann Neurol; 1999 Aug; 46(2):197-206. PubMed ID: 10443885 [TBL] [Abstract][Full Text] [Related]
76. Interferon treatment for multiple sclerosis patients in Hong Kong. Lau KK; Lee PO; Chan KY; Chan YW; Chin KF Hong Kong Med J; 2000 Jun; 6(2):221-3. PubMed ID: 10895148 [TBL] [Abstract][Full Text] [Related]